Model
Edge
Alnylam Pharmaceuticals, Inc.
0001438226
Filing Type
4
Filing Date
5/21/2026
Updated
5/22/26, 2:18 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership